DR5 is a restriction factor for human herpesviruses.

Area of Science:

• Virology
• Immunology
• Cell Biology

Background:

• Restriction factors are crucial innate immune proteins that limit viral replication.
• Kaposi sarcoma-associated herpesvirus (KSHV) is a human herpesvirus with a complex life cycle.
• The extrinsic apoptotic pathway, involving DR5, plays a role in cellular defense mechanisms.

Purpose of the Study:

• To investigate the role of DR5 as a restriction factor against KSHV.
• To identify evolutionary adaptations in DR5 related to antiviral activity.
• To understand the mechanisms by which KSHV evades DR5-mediated inhibition.

Main Methods:

• Apoptosis assays to assess KSHV replication inhibition by DR5.
• Evolutionary sequence analysis of DR5 in primates.
• Site-directed mutagenesis to study the function of specific DR5 residues (e.g., A62).
• Co-immunoprecipitation and degradation assays to investigate KSHV K5 protein interaction with DR5.

Main Results:

• DR5 internalization induces apoptosis, inhibiting KSHV lytic replication.
• Evolutionary analysis identified positive selection sites in DR5, with A62 being critical for antiviral function and ligand binding.
• DR5 demonstrated broad-spectrum antiviral activity against multiple herpesviruses (EBV, HSV-1, HSV-2).
• KSHV K5 protein targets DR5 for degradation via lysosomal and proteasomal pathways, with lysine 245 being essential for this process.

Conclusions:

• DR5 functions as a potent restriction factor against human herpesviruses, including KSHV.
• The A62 residue is a key evolutionary adaptation conferring antiviral properties to DR5.
• KSHV employs viral proteins like K5 to counteract DR5-mediated restriction through protein degradation.